presentation slides: mucicrew-x
TRANSCRIPT
Presentation by:
Jonathan Collins, Lorenzo Fertitta, Katie Hango, Tim Kiernan, Danny McConnell, Devin McNamara, AnishaPatel, Michael Rees, Ian Simpson, Michael Waterfield
Today’s Presentation
• Interactive Technology
• Target Market
• SWOT Analysis Highlights
• Central Communications Theme
• Differentiator/Promotional Schedule
• Allocation of Budget
Millennials 1. Low Brand Loyalty
2. Value Effective and Fast Acting Medicine
3. Exposure to Social Media and Mobile Advertising
4. Utilization of TabletsTarget Consumer: “Max”
SWOT Analysis Highlights
Strength: Maximum Effectiveness
Weakness: Low Brand Loyalty
Opportunity: Online/Mobile Marketing to Millennials
Threat: CompetitorsVicks, Alka-Seltzer, Tylenol
Perceptual MapVery Effective
High Brand
Recognition
Not Effective
Low Brand
Recognition
Overview of Budget
Total amount spent: $2,948,300
Snapchat27%
Hulu17%
Youtube17%
Interactive Pad Display
17%
Interactive Pads22%
Snapchat
Hulu
Youtube
Interactive Pad Display
Interactive Pads
Index Slide
• Google Flu Trends
• Primary Research Support
• SWOT Analysis
• SWOT Analysis Matrix
• Detailed Marketing Budget
Primary Research Support
Strength
Taste
Brand Recog.
Price
65.82%
7.59%
10.13%
12.66%
25.32%
12.66%
34.18%
27.85%7.59%
30.38%
29.11%32.91%
0.27%
48.10%
25.32%
25.32%
Product Attribute Ranking
1
2
3
4
Return to Index
SWOT Analysis MatrixStrengths Weaknesses
Opportunities -To take advantage of the younger consumer base
and the changing age dynamic of the population,
Mucinex can utilize its strong brand personality of
being devoted to each and every customer's well-
being
- Because Walmart shoppers are considered “smart-
shoppers”, Mucinex can easily demonstrate the added
benefit and value which their brand offers, gaining the
market share of these “smart-shoppers”
-Although brand loyalty of Mucinex is low, the emerging
millennial market and changing age dynamic of the
population creates opportunities for Mucinex to gain loyalty
through a different target market that previously did not exist
Threats -Although the private label multi-symptom medicine
brands are gaining market share, they do not promise
the sort of brand personality and commitment to
consumers that Mucinex provides; thus, Mucinex can
emphasize its brand values to combat the threats of
private label brands
-To manage the threat of an increase of low-income
consumers and households, Mucinex can emphasize
the power and effectiveness of their brand to show the
premium that Mucinex puts on their multi-symptom
medicines; thus, showing the added value for the
added price
-Due to the “barbell economy” creating a vast range of
incomes, we plan to focus on segmenting the market and
choosing a target market since Mucinex has low perceived
trustworthiness and low market share; which does not allow
us to effectively attract all consumers
-Since private label brands attract a large percentage of
consumers due to their cheap prices, we will avoid targeting
them as one of our main competitors since our low brand
loyalty and high prices minimize the opportunities we have in
taking market share from these brands
Return to Index
Detailed Marketing BudgetPromotion Category Promotional Tool Duration Total Cost
Mobile Advertising Snap Chat 2 months (October-November) $400,000
Snap Chat 2 months (February-March) $400,000
Cost of Supplies Snap Chat $0
Total Category Cost: $800,000
Online Advertising Hulu 2 Months(December-January) $500,000
YouTube 2 Months (December-January) $500,000
Total Category Cost: $1,000,000
Calculation of CPM CPM Total Impressions
YouTube $13.00 38,461,538
Hulu $13.00 38,461,538
In-Store Advertising Interactive Pad Display 2 months (December-January) $500,000
Cost of Supplies Interactive Pads (IPads) $648,300
Total Category Cost: $1,148,300
Total Marketing Cost: $2,948,300
Return to Index